Comorbidity in heart failure. Results of the Spanish RICA Registry

F-J Ruiz-Laiglesia1, M Sánchez-Marteles2, J-I Pérez-Calvo2

  • 1From the Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Department of Internal Medicine, Hospital Universitario de Bellvitge, Hospitalet de Llobregat, Barcelona, Department of Internal Medicine, Hospital de Fuenlabrada, Fuenlabrada, Madrid, Department of Internal Medicine, Hospital Universitari de Girona Dr. Josep Trueta, Girona, Department of Internal Medicine, Hospital Costa del Sol, Marbella Málaga, Department of Internal Medicine, Consorcio Hospital General Universitario de Valencia, Valencia, Department of Internal Medicine, Hospital Municipal de Badalona, Badalona, Barcelona and Department of Internal Medicine, IMIBIC/Hospital Universitario Reina Sofía, Córdoba, Spain fruizl@unizar.es.

Insights

Heart failure (HF) is often accompanied by multiple comorbidities. The Charlson Comorbidity Index (ChI) effectively predicts mortality and rehospitalization risk in HF patients, guiding comprehensive care.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Geriatrics

Background:

  • Heart failure (HF) frequently presents with comorbidities, impacting patient outcomes.
  • Identifying these comorbidities is crucial for managing HF patients.

Purpose of the Study:

  • To identify comorbidities associated with heart failure (HF).
  • To assess the influence of comorbidities on mortality and rehospitalization in HF patients.

Main Methods:

  • Analysis of data from the 'Registro de Insuficiencia Cardiaca' (RICA) registry.
  • Inclusion of 2051 patients admitted for acute HF.
  • Assessment of comorbidities using the Charlson Index (ChI), age, gender, LVEF, and Barthel Index.

Main Results:

  • Common comorbidities included diabetes mellitus, chronic renal impairment, and COPD.
  • Age, myocardial infarction, dementia, COPD, renal impairment, and diabetes were independent prognostic factors.
  • The Charlson Index (ChI) emerged as the sole independent prognostic factor for combined rehospitalization and death (P < 0.001).

Conclusions:

  • Heart failure is a condition characterized by significant comorbidity.
  • The Charlson Index (ChI) is a practical tool for assessing comorbidity burden in HF.
  • A holistic approach to HF management can improve prognosis and reduce healthcare system strain.
Abstract

Related Concept Videos

Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
1.1K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.7K
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
886
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.6K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
616
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.7K